We believe the pemvidutide data showing significant weight loss, combined with robust reductions in liver fat content, serum lipids and blood pressure without cardiovascular safety signals could offer a differentiated product profile that meaningfully impacts patients with obesity and NAFLD or dyslipidemia, and patients with NASH.”
Alt yahoo finance trial#
We are also eager to report our 48-week data from the MOMENTUM Phase 2 obesity trial next quarter. “We believe our compelling Phase 1b data in subjects with nonalcoholic fatty liver disease (NAFLD) demonstrating class-leading improvements in liver fat and markers of liver inflammation support the prospects of achieving robust rates of NASH resolution and fibrosis improvement in our IMPACT trial. Garg, Ph.D., President and Chief Executive Officer of Altimmune. “We are pleased to have commenced enrollment in our IMPACT Phase 2b biopsy-driven trial of pemvidutide in NASH,” said Vipin K. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the three months ended June 30, 2023, and provided a business update. 10, 2023 (GLOBE NEWSWIRE) - Altimmune, Inc. Webcast to be held today, August 10, 2023, at 8:30 am EDT Top-line results from the Phase 2 trial of HepTcell™ in chronic hepatitis B (CHB) expected Q1 2024
You should review your particular circumstances with your independent legal and tax advisors.Top-line 48-week results from the MOMENTUM Phase 2 obesity trial expected Q4 2023Ĭommenced enrollment in IMPACT Phase 2b trial of pemvidutide in non-alcoholic steatohepatitis (NASH) and its affiliates do not provide legal or tax advice to clients.
This information is being used to support the promotion or marketing of the planning strategies discussed herein. This information cannot be used by any taxpayer for the purpose of avoiding tax penalties that may be imposed on the taxpayer.
This information is not intended to be tax or legal advice. Please review the privacy and security policies of web sites reached through links from BMO web sites. Links to other web sites do not imply the endorsement or approval of such web sites. Third party web sites may have privacy and security policies different from BMO. If the requested information is not provided within 30 calendar days, the account will be subject to closure. The information you provide in this form may be used to perform a credit check and verify your identity by using internal sources and third party vendors. We may also ask you to provide a copy of your certificate of incorporation (or similar document) or other identifying documents. For each business or entity that opens an account, we will ask for your name, address and other information that will allow us to identify the entity.
Alt yahoo finance license#
We may also ask you to provide a copy of your driver's license or other identifying documents. When you open an account, we will ask for your name, address, date of birth and other information that will allow us to identify you. 107 56 signed into law October 26, 2001) requires all financial organizations to obtain, verify and record information that identifies each person who opens an account. To help the government fight the funding of terrorism and money laundering activities, federal law (USA Patriot Act (Title III of Pub. and other countries.Īndroid, Google Play, and the Google Play logo are trademarks of Google Inc.īanking products and services are subject to bank and credit approval and are provided in the United States by BMO Bank N.A. Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. App Store is a service mark of Apple Inc.
0 kommentar(er)
